Merion, PA, United States of America

Barbara L Weber


 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Barbara L. Weber in Cancer Genetics

Introduction

Barbara L. Weber is a distinguished inventor based in Merion, PA, USA. She has significantly contributed to the field of human genetics, focusing on breast cancer susceptibility. With a total of three patents to her name, Barbara's pioneering work addresses critical aspects of cancer diagnostics and therapy.

Latest Patents

Among her notable contributions is the patent related to the Chromosome 13-linked breast cancer susceptibility gene, specifically targeting the BRCA2 gene. This invention encompasses methods and materials for isolating and detecting the BRCA2 gene, which is critical for identifying individuals predisposed to breast cancer. It explores germline mutations within the BRCA2 gene, which play a vital role in diagnostics, and further investigates somatic mutations in relation to human breast cancer and other cancers. The patent also includes therapeutic approaches for cancers associated with BRCA2 mutations, such as gene therapy and drug screening methods for effective cancer treatment.

Career Highlights

Barbara has garnered experience working at reputable companies, including Endorecherche, Inc. and Myriad Genetics, Inc. Throughout her career, she has established herself as a leading figure in cancer genetics research, significantly impacting the understanding of hereditary cancer risks.

Collaborations

Barbara has collaborated with accomplished colleagues such as Sean V. Tavtigian and Alexander Kamb. These partnerships have enhanced interdisciplinary dynamics in their research endeavors, contributing to advancements in genetic testing and cancer treatment.

Conclusion

In conclusion, Barbara L. Weber's work in the field of cancer genetics represents a crucial leap forward in our understanding of breast cancer predisposition. Her patents highlight innovative approaches to diagnosis and therapy, showcasing her dedication to improving cancer outcomes through genetic research. Barbara's contributions reflect a profound commitment to the betterment of public health and the advancement of scientific knowledge in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…